Human papillomavirus (HPV) is a ubiquitous human pathogen that causes cervical and
other anogenital cancers as well as genital warts and recurrent respiratory papillomatosis …

Human papillomaviruses cause the most common sexually transmitted infection in the world
and are responsible for nearly all cases of cervical cancer. Genital human papillomavirus …

Over the past few decades, epidemiology and natural history studies have led to improved
understanding of human papillomavirus (HPV) infection and to promising prevention …

Vaccines for preventing human papillomavirus (HPV) infection are far along in clinical
development and testing and hold great promise for reducing HPV infections and HPV …

The majority of cervical cancers result when the human papillomavirus (HPV) is transmitted
from a man to a woman during vaginal intercourse. Several factors, including vaginal …

Purpose. Human papillomavirus (HPV) disease and vaccines and several controversial
issues associated with vaccine administration are reviewed. Summary. HPV infection is the …

Introduction: The 9-valent human papillomavirus (9vHPV) vaccine covers the same HPV
types (6/11/16/18) as the quadrivalent HPV (qHPV) vaccine and 5 additional cancer-causing …

Background: A prophylactic quadrivalent human papillomavirus (HPV) vaccine could benefit
adult women if they are susceptible to incident genital HPV infections and are acquiring new …

Human papillomavirus (HPV) is a highly prevalent, sexually transmitted infection
responsible for significant morbidity and mortality. High-risk HPV types are now known to be …

Background Human papillomavirus (HPV) vaccines were designed to prevent cervical
cancer in women and their provision remains a major public health need. However, HPV is …